<DOC>
	<DOC>NCT00555672</DOC>
	<brief_summary>The purpose of this study is to determine the safe and tolerable dose of sunitinib when given together with cisplatin and 5-fluorouracil in patients with advanced gastric cancer who have not received prior chemotherapy for their advanced cancer.</brief_summary>
	<brief_title>Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>confirmed diagnosis of stomach cancer advanced stomach cancer stage IV adequate blood chemistry, blood counts and kidney function willing to participate to study requirements and to sign an informed consent document prior chemotherapy for stomach cancer in its advanced stage excessive toxicities related to prior therapies pregnant or breastfeeding patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>